The global biopharma industry moves fast, and having outdated information and data can put you at a strategic and competitive disadvantage. Our BioPharm Solutions Suite features daily updates, real-time alerts and investigative journalism with Active Intel to ensure our subscribers have the reliable trend data and forward-looking intelligence they need to shape the global biopharma industry according to their vision.
Market and Competitive Intelligence
BioPharm Insight features an independent team of global investigative journalists providing a daily stream of proprietary and fact-based intelligence predicting market-moving events 6-to-12 months in advance to help subscribers understand and interact with their industry. Due to their independence from traditional business influences, BioPharm Insight journalists are uniquely positioned to cultivate strong relationships including CEOs and other executives, researchers, lawyers, analysts and more. This distinguished service provides subscribers with an undisputed information edge over their competition.
Our comprehensive solutions aggregate data from numerous disparate sources and consolidate it into usable and searchable online databases, layered with analytics and powered by detailed profiles on companies, pipelines, drugs/devices, clinical activities, indications, financial deals, sales forecasts and more. Using our Active Intel technology, all forward-looking intelligence is seamlessly integrated with these robust data sets.
Biopharma drugs | Medical devices